How many is good enough? An analysis of serological follow-up after vaccination against SARS-CoV-2

[1] Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, et al. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report. N Engl J Med. 2020;383:1920–31. JacksonLA AndersonEJ RouphaelNG RobertsPC MakheneM ColerRN McCulloughMP ChappellJD DenisonMR StevensLJ An mRNA Vaccine against SARS-CoV-2 - Preliminary Report N Engl J Med. 2020 383 1920 31 Search in Google Scholar

[2] Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin GE, Rubin C, Indenbaum V, et al. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers. N Engl J Med. 2021;385:1474–84. BergwerkM GonenT LustigY AmitS LipsitchM CohenC MandelboimM LevinGE RubinC IndenbaumV Covid-19 Breakthrough Infections in Vaccinated Health Care Workers N Engl J Med. 2021 385 1474 84 Search in Google Scholar

[3] Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021 Jul;27:1205–11. KhouryDS CromerD ReynaldiA SchlubTE WheatleyAK JunoJA SubbaraoK KentSJ TriccasJA DavenportMP. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection Nat Med. 2021 Jul 27 1205 11 Search in Google Scholar

[4] Jones JM, Stone M, Sulaeman H, Fink RV, Dave H, Levy ME, Di Germanio C, Green V, Notari E, Saa P, et al. Estimated US Infection-and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020–May 2021. JAMA. 2021;326:1400–9. JonesJM StoneM SulaemanH FinkRV DaveH LevyME Di GermanioC GreenV NotariE SaaP Estimated US Infection-and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020–May 2021 JAMA. 2021 326 1400 9 Search in Google Scholar

[5] WHO/BS.2020.2403 Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody [Internet]. [cited 2023 Feb 24]. Available from: https://www.who.int/publications/m/item/WHO-BS-2020.2403. WHO/BS 2020.2403 Establishment of the WHO International Standard and Reference Panel for anti-SARS-CoV-2 antibody [Internet] [cited 2023 Feb 24]. Available from: https://www.who.int/publications/m/item/WHO-BS-2020.2403. Search in Google Scholar

[6] Knezevic I, Mattiuzzo G, Page M, Minor P, Griffiths E, Nuebling M, Moorthy V. WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community. Lancet Microbe. 2022 Mar 1;3:e235–40. KnezevicI MattiuzzoG PageM MinorP GriffithsE NueblingM MoorthyV. WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community Lancet Microbe. 2022 Mar 1 3 e235 40 Search in Google Scholar

[7] Schuh AJ, Satheshkumar PS, Dietz S, Bull-Otterson L, Charles M, Edens C, Jones JM, Bajema KL, Clarke KEN, McDonnald LC, et al. SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection. Microbiol Spectr. 2022 Aug 31;10:e0124722. SchuhAJ SatheshkumarPS DietzS Bull-OttersonL CharlesM EdensC JonesJM BajemaKL ClarkeKEN McDonnaldLC SARS-CoV-2 Convalescent Sera Binding and Neutralizing Antibody Concentrations Compared with COVID-19 Vaccine Efficacy Estimates against Symptomatic Infection Microbiol Spectr. 2022 Aug 31 10 e0124722 Search in Google Scholar

[8] Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM, Planchais C, Porrot F, Robillard N, Puech J, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature. 2021 Aug;596:276–80. PlanasD VeyerD BaidaliukA StaropoliI Guivel-BenhassineF RajahMM PlanchaisC PorrotF RobillardN PuechJ Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization Nature. 2021 Aug 596 276 80 Search in Google Scholar

[9] Goldberg Y, Mandel M, Bar-On YM, Bodenheimer O, Freedman L, Haas EJ, Milo R, Alroy-Preis S, Ash N, Huppert A Waning Immunity after the BNT162b2 Vaccine in Israel. N Engl J Med. 2021;NEJMoa2114228. GoldbergY MandelM Bar-OnYM BodenheimerO FreedmanL HaasEJ MiloR Alroy-PreisS AshN HuppertA Waning Immunity after the BNT162b2 Vaccine in Israel N Engl J Med. 2021 NEJMoa2114228 Search in Google Scholar

[10] Pouwels KB, Pritchard E, Matthews PC, Stoesser N, Eyre DW, Vihta KD, House T, Hay J, Bell JI, Newton JN et al. Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. Nat Med. 2021 Dec;27:2127–35. PouwelsKB PritchardE MatthewsPC StoesserN EyreDW VihtaKD HouseT HayJ BellJI NewtonJN Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK Nat Med. 2021 Dec 27 2127 35 Search in Google Scholar

[11] Callaway E. COVID drug drives viral mutations - and now some want to halt its use. Nature. 2023;614:399. CallawayE. COVID drug drives viral mutations - and now some want to halt its use Nature. 2023 614 399 Search in Google Scholar

[12] Reynolds CJ, Gibbons JM, Pade C, Lin KM, Sandoval DM, Pieper F, Butler DK, Liu S, Otter AD, Joy G, et al. Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants. Science. 2022 Jan 14;375(6577):183–92. ReynoldsCJ GibbonsJM PadeC LinKM SandovalDM PieperF ButlerDK LiuS OtterAD JoyG Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants Science. 2022 Jan 14 375 6577 183 92 Search in Google Scholar

[13] Brazil R. How your first brush with COVID warps your immunity. Nature. 2023 Jan 18;613:428–30. BrazilR. How your first brush with COVID warps your immunity Nature. 2023 Jan 18 613 428 30 Search in Google Scholar

[14] Cao Y, Jian F, Wang J, Yu Y, Song W, Yisimayi A, Wang J, An R, Chen X, Zhang N, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2023;614:521–9. CaoY JianF WangJ YuY SongW YisimayiA WangJ AnR ChenX ZhangN Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution Nature. 2023 614 521 9 Search in Google Scholar

[15] Wang Q, Bowen A, Valdez R, Gherasim C, Gordon A, Liu L, Ho DD Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot [Internet]. bioRxiv; 2022 [cited 2023 Feb 27]. p. 2022.10.22.513349. Available from: https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1. WangQ BowenA ValdezR GherasimC GordonA LiuL HoDD Antibody responses to Omicron BA. 4/BA.5 bivalent mRNA vaccine booster shot [Internet] bioRxiv 2022 [cited 2023 Feb 27]. p. 2022.10.22.513349. Available from: https://www.biorxiv.org/content/10.1101/2022.10.22.513349v1. Search in Google Scholar

[16] Collier A ris Y, Miller J, Hachmann NP, McMahan K, Liu J, Bondzie EA, Gallup L, Rowe M, Schonberg E, Thai S, et al. Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters [Internet]. bioRxiv; 2022 [cited 2023 Feb 27]. p. 2022.10.24.513619. Available from: https://www.biorxiv.org/content/10.1101/2022.10.24.513619v1. CollierA ris Y MillerJ HachmannNP McMahanK LiuJ BondzieEA GallupL RoweM SchonbergE ThaiS Immunogenicity of the BA.5 Bivalent mRNA Vaccine Boosters [Internet] bioRxiv 2022 [cited 2023 Feb 27]. p. 2022.10.24.513619. Available from: https://www.biorxiv.org/content/10.1101/2022.10.24.513619v1. Search in Google Scholar

[17] Aydillo T, Rombauts A, Stadlbauer D, Aslam S, Abelenda-Alonso G, Escalera A, Amanat F, Jiang K, Krammer F, Carratala J, et al. Immunological imprinting of the antibody response in COVID-19 patients. Nat Commun [Internet]. 2021 Jun 18 [cited 2023 Feb 27];12. Available from: https://pubmed.ncbi.nlm.nih.gov/34145263/ AydilloT RombautsA StadlbauerD AslamS Abelenda-AlonsoG EscaleraA AmanatF JiangK KrammerF CarratalaJ Immunological imprinting of the antibody response in COVID-19 patients Nat Commun [Internet] 2021 Jun 18 [cited 2023 Feb 27];12. Available from: https://pubmed.ncbi.nlm.nih.gov/34145263/ Search in Google Scholar

[18] Pérez-Alós L, Armenteros JJA, Madsen JR, Hansen CB, Jarlhelt I, Hamm SR, Heftdal LD, Pries-Heje MM, Moller DL, Fogh K, et al. Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors. Nat Commun. 2022 Mar 28;13:1614. Pérez-AlósL ArmenterosJJA MadsenJR HansenCB JarlheltI HammSR HeftdalLD Pries-HejeMM MollerDL FoghK Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors Nat Commun. 2022 Mar 28 13 1614 Search in Google Scholar

[19] Forgacs D, Silva-Moraes V, Sautto GA, Hanley HB, Gattiker JL, Jefferson AM, Kolhe R, Ross TM The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination. Vaccines. 2022 May;10:696. ForgacsD Silva-MoraesV SauttoGA HanleyHB GattikerJL JeffersonAM KolheR RossTM The Effect of Waning on Antibody Levels and Memory B Cell Recall following SARS-CoV-2 Infection or Vaccination Vaccines. 2022 May 10 696 Search in Google Scholar

[20] Skorupa M, Szczepanek J, Goroncy A, Jarkiewicz-Tretyn J, Ptaszyńska B, Rajewski P, Koper W, Pałgan K, Tretyn A The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines. Vaccines. 2022 Apr;10:506. SkorupaM SzczepanekJ GoroncyA Jarkiewicz-TretynJ PtaszyńskaB RajewskiP KoperW PałganK TretynA The Dynamics of Changes in the Concentration of IgG against the S1 Subunit in Polish Healthcare Workers in the Period from 1 to 12 Months after Injection, Including Four COVID-19 Vaccines Vaccines. 2022 Apr 10 506 Search in Google Scholar

[21] Luczkowiak J, Labiod N, Rivas G, Rolo M, Lasala F, Lora-Tamayo J, Mancheno-Losa M, Rial D, Peres-Rivilla A, Folgueira MD, et al. Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals. Open Forum Infect Dis. 2021;8:ofab468. LuczkowiakJ LabiodN RivasG RoloM LasalaF Lora-TamayoJ Mancheno-LosaM RialD Peres-RivillaA FolgueiraMD Prime-Boost Vaccination With BNT162b2 Induces High Neutralizing Activity Against SARS-CoV-2 Variants in Naïve and COVID-19-Convalescent Individuals Open Forum Infect Dis. 2021 8 ofab468 Search in Google Scholar

[22] Levin EG, Lustig Y, Cohen C, Fluss R, Indenbaum V, Amit S, Doolman R, Asraf K, Mendelson E, Ziv A, et al. Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months. N Engl J Med. 2021 Dec 9;385:e84. LevinEG LustigY CohenC FlussR IndenbaumV AmitS DoolmanR AsrafK MendelsonE ZivA Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months N Engl J Med. 2021 Dec 9 385 e84 Search in Google Scholar

[23] Thomas SJ, Moreira ED, Kitchin N, Absalon J, Gurtman A, Lockhart S, Peres JL, Marc GP, Polack FP, Zerbini C, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med. 2021;385:1761–73. ThomasSJ MoreiraED KitchinN AbsalonJ GurtmanA LockhartS PeresJL MarcGP PolackFP ZerbiniC Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months N Engl J Med. 2021 385 1761 73 Search in Google Scholar

[24] Singanayagam A, Hakki S, Dunning J, Madon KJ, Crone MA, Koycheva A, Derqui-Fernandez N, Barnett JL, Whitfield MG, Varro R, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2022;22:183–95. SinganayagamA HakkiS DunningJ MadonKJ CroneMA KoychevaA Derqui-FernandezN BarnettJL WhitfieldMG VarroR Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study Lancet Infect Dis. 2022 22 183 95 Search in Google Scholar

[25] Francis T, Salk JE, Quilligan JJ. Experience with Vaccination Against Influenza in the Spring of 1947. Am J Public Health Nations Health. 1947 Aug;37:1013–6. FrancisT SalkJE QuilliganJJ. Experience with Vaccination Against Influenza in the Spring of 1947 Am J Public Health Nations Health. 1947 Aug 37 1013 6 Search in Google Scholar

[26] Marzi R, Bassi J, Silacci-Fregni C, Bartha I, Muoio F, Culap K, Sprugasci N, Lombardo G, Saliba C, Cameroni E, et al. Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape. iScience. 2023 Jan 20;26:105726. MarziR BassiJ Silacci-FregniC BarthaI MuoioF CulapK SprugasciN LombardoG SalibaC CameroniE Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape iScience. 2023 Jan 20 26 105726 Search in Google Scholar

[27] King SM, Bryan SP, Hilchey SP, Wang J, Zand MS. First Impressions Matter: Immune Imprinting and Antibody Cross-Reactivity in Influenza and SARS-CoV-2. Pathogens. 2023;12:169. KingSM BryanSP HilcheySP WangJ ZandMS. First Impressions Matter: Immune Imprinting and Antibody Cross-Reactivity in Influenza and SARS-CoV-2 Pathogens. 2023 12 169 Search in Google Scholar

[28] Tober-Lau P, Schwarz T, Vanshylla K, Hillus D, Gruell H, EICOV/COVIM Study Group, Suttorp N, Landgraf I, Kappert K, Seybold J, et al. Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers. Lancet Respir Med. 2021;9:e104–5. Tober-LauP SchwarzT VanshyllaK HillusD GruellH EICOV/COVIM Study Group SuttorpN LandgrafI KappertK SeyboldJ Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers Lancet Respir Med. 2021 9 e104 5 Search in Google Scholar

[29] Bates TA, Leier HC, Lyski ZL, Goodman JR, Curlin ME, Messer WB, Tafesse FG Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples. JAMA. 2021 Jul 21;326:868–9. BatesTA LeierHC LyskiZL GoodmanJR CurlinME MesserWB TafesseFG Age-Dependent Neutralization of SARS-CoV-2 and P.1 Variant by Vaccine Immune Serum Samples JAMA. 2021 Jul 21 326 868 9 Search in Google Scholar

[30] Yang HS, Costa V, Racine-Brzostek SE, Acker KP, Yee J, Chen Z, Karbaschi M, Zuk R, Rand S, Sukhu A, et al. Association of Age With SARS-CoV-2 Antibody Response. JAMA Netw Open. 2021 Mar 1;4:e214302. YangHS CostaV Racine-BrzostekSE AckerKP YeeJ ChenZ KarbaschiM ZukR RandS SukhuA Association of Age With SARS-CoV-2 Antibody Response JAMA Netw Open. 2021 Mar 1 4 e214302 Search in Google Scholar

[31] Szczepanek J, Skorupa M, Goroncy A, Jarkiewicz-Tretyn J, Wypych A, Sandomierz D, Jarkiewicz-Tretyn J, Dejewska J, Ciechanowska K, Pałgan K, et al. Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines. Vaccines. 2022 Jan;10:99. SzczepanekJ SkorupaM GoroncyA Jarkiewicz-TretynJ WypychA SandomierzD Jarkiewicz-TretynJ DejewskaJ CiechanowskaK PałganK Anti-SARS-CoV-2 IgG against the S Protein: A Comparison of BNT162b2, mRNA-1273, ChAdOx1 nCoV-2019 and Ad26.COV2.S Vaccines Vaccines. 2022 Jan 10 99 Search in Google Scholar

[32] Faizo AA, Qashqari FS, El-Kafrawy SA, Barasheed O, Almashjary MN, Alfelali M, Bawazir AA, Albarakati BM, Khayyat SA, Hassan AM, et al. A potential association between obesity and reduced effectiveness of COVID-19 vaccine-induced neutralizing humoral immunity. J Med Virol. 2023 Jan;95:e28130. FaizoAA QashqariFS El-KafrawySA BarasheedO AlmashjaryMN AlfelaliM BawazirAA AlbarakatiBM KhayyatSA HassanAM A potential association between obesity and reduced effectiveness of COVID-19 vaccine-induced neutralizing humoral immunity J Med Virol. 2023 Jan 95 e28130 Search in Google Scholar

[33] Klaauw AA van der, Horner EC, Pereyra-Gerber P, Agrawal U, Foster WS, Spencer S, Vergese B, Smith M, Henning E, Ramsay ID, et al. Accelerated waning of the humoral response to SARS-CoV-2 vaccines in obesity [Internet]. medRxiv; 2022 [cited 2023 Feb 27]. p. 2022.06.09.22276196. Available from: https://www.medrxiv.org/content/10.1101/2022.06.09.22276196v1. KlaauwAA van der HornerEC Pereyra-GerberP AgrawalU FosterWS SpencerS VergeseB SmithM HenningE RamsayID Accelerated waning of the humoral response to SARS-CoV-2 vaccines in obesity [Internet] medRxiv 2022 [cited 2023 Feb 27]. p. 2022.06.09.22276196. Available from: https://www.medrxiv.org/content/10.1101/2022.06.09.22276196v1. Search in Google Scholar

[34] Zhu Q, Zhang Y, Kang J, Chen Z, Peng M, Chen M, Zhang G, Xiang D, Xiao S, Li H, et al. Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight. Genes Dis. 2022. ZhuQ ZhangY KangJ ChenZ PengM ChenM ZhangG XiangD XiaoS LiH Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight Genes Dis. 2022 Search in Google Scholar

[35] Ferrara P, Gianfredi V, Tomaselli V, Polosa R. The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies. Vaccines. 2022;10:303. FerraraP GianfrediV TomaselliV PolosaR. The Effect of Smoking on Humoral Response to COVID-19 Vaccines: A Systematic Review of Epidemiological Studies Vaccines. 2022 10 303 Search in Google Scholar

[36] Ferrara P, Ponticelli D, Agüero F, Caci G, Vitale A, Borrelli M, Schiavone B, Antonazzo IC, Mantovani LG, Tomaselli V, et al. Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies. Public Health. 2022;203:97–9. FerraraP PonticelliD AgüeroF CaciG VitaleA BorrelliM SchiavoneB AntonazzoIC MantovaniLG TomaselliV Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies Public Health. 2022 203 97 9 Search in Google Scholar

[37] Poniedziałek B, Hallmann E, Sikora D, Szymański K, Kondratiuk K, Żurawski J, Rzymski P, Brydak L Relationship between Humoral Response in COVID-19 and Seasonal Influenza Vaccination. Vaccines. 2022;10:1621. PoniedziałekB HallmannE SikoraD SzymańskiK KondratiukK ŻurawskiJ RzymskiP BrydakL. Relationship between Humoral Response in COVID-19 and Seasonal Influenza Vaccination Vaccines. 2022 10 1621 Search in Google Scholar